Moreover, pharmacological inhibition of USP25 reversed amyloid pathology in 5×FAD mice, suggesting that USP25 inhibition could be an effective strategy for alleviating amyloid deposition in the AD brain (Figure 9). This evidence concerns the gene USP25 and Alzheimer disease.